BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 27573897)

  • 1. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer.
    Kumegawa K; Maruyama R; Yamamoto E; Ashida M; Kitajima H; Tsuyada A; Niinuma T; Kai M; Yamano HO; Sugai T; Tokino T; Shinomura Y; Imai K; Suzuki H
    Sci Rep; 2016 May; 6():26699. PubMed ID: 27215978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
    Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
    J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of epigenetic pattern of long noncoding RNA loci in colorectal cancer.
    Liao Q; Chen L; Liu J; Yang T; Li J; Zhang X; Zhao J
    Gene; 2016 Dec; 595(1):9-17. PubMed ID: 27642123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Mol Oncol; 2012 Dec; 6(6):567-78. PubMed ID: 22902148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
    Jacinto FV; Ballestar E; Esteller M
    Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours.
    Kashani E; Hadizadeh M; Chaleshi V; Mirfakhraie R; Young C; Savabkar S; Irani S; Asadzadeh Aghdaei H; Ashrafian Bonab M
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31546665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
    Chen H; Xu Z
    Dis Markers; 2015; 2015():345080. PubMed ID: 26693202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
    Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC
    Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.
    Grady WM; Parkin RK; Mitchell PS; Lee JH; Kim YH; Tsuchiya KD; Washington MK; Paraskeva C; Willson JK; Kaz AM; Kroh EM; Allen A; Fritz BR; Markowitz SD; Tewari M
    Oncogene; 2008 Jun; 27(27):3880-8. PubMed ID: 18264139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.